FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe
In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients
First Compound From New In Vitro Screening to Enter Clinical Trials
DCBD Board Okays Concept for Animal Holding Recompetition
Minorities Increasingly Involved In Research, Training Programs
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.”









